Vaughan Feisst

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Highly Efficient

Top Venues

Bioengineering & translational medicine

International journal of molecular sciences

Cancer immunology research

Molecular diagnosis & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Alex du Rand, John Murray Topp Hunt, Christopher Allan Samson, Evert Jan Loef, Chloe Malhi, Sarah Meidinger, Chun-Jen Jennifer Chen, Ashley Nutsford, John Taylor, Rod Dunbar, Diana Purvis, Vaughan Feisst, Hilary M Sheppard
Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa. Bioengineering & translational medicine 9 (4) (2024)
Alex du Rand, John Murray Topp Hunt, Christopher Allan Samson, Evert Jan Loef, Chloe Malhi, Sarah Meidinger, Chun-Jen Jennifer Chen, Ashley Nutsford, John Taylor, Rod Dunbar, Diana Purvis, Vaughan Feisst, Hilary M Sheppard
Highly efficient CRISPR/Cas9-mediated exon skipping for recessive dystrophic epidermolysis bullosa. Bioengineering & translational medicine 9 (4) (2024)
Alex du Rand, John M T Hunt, Vaughan Feisst, Hilary M Sheppard
Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat Wounds. Molecular diagnosis & therapy 26 (6) (2022)
Megan Iminitoff, Tanvi Damani, Eloise Williams, Anna E S Brooks, Vaughan Feisst, Hilary M Sheppard
microRNAs in Ex Vivo Human Adipose Tissue Derived Mesenchymal Stromal Cells (ASC) Undergo Rapid Culture-Induced Changes in Expression, Including miR-378 which Promotes Adipogenesis. International journal of molecular sciences 21 (4) (2020)
Jennifer Eom, Saem Mul Park, Vaughan Feisst, Chun-Jen J Chen, Joanna E Mathy, Julie D McIntosh, Catherine E Angel, Adam Bartlett, Richard Martin, Jonathan S Cebon, Michael A Black, Anna E S Brooks, P Rod Dunbar
Distinctive Subpopulations of Stromal Cells Are Present in Human Lymph Nodes Infiltrated with Melanoma. Cancer immunology research 8 (8) (2020)